Lansoprazole and omeprazole degrade in water leading to sulfides, benzimidazolones and a red complex material. Degradation is accelerated in acid medium and by solar simulator irradiation. Benzimidazoles, dianilines and pyridines have also been identified.

A simple and highly sensitive high-performance liquid chromatography (HPLC) method for the simultaneous quantitative determination of lansoprazole enantiomers and their metabolites, 5-hydroxylansoprazole enantiomers and lansoprazole sulfone, in human plasma have been developed. Chromatographic s...

Indolo[2,3-a]carbazole based inhibitors were synthesized from readily available indigo via a seven-step linear synthetic sequence with a moderate overall yield. The inhibitors were selectively and readily functionalized at the nitrogen on the indole portion of the carbazole unit. The synthesized...

A series of new 1,4 disubstituted (1-alkyl-1H-1,2,3-triazol-4-yl)methyl-2H-chromene-3-carboxylates (4ai–4eiii) have been efficiently synthesized in moderate to excellent yields by the 1,3 dipolar cycloaddition between 2-propynyl-2H-chromene-3-carboxylates 3a–e and various alkyl azides under Cu...

Mercapturic acid pathway metabolites of phenylethyl isothiocyanate inhibited the growth of human leukaemia 60 (HL60) cells in vitro. The adduct with l-cysteine, S-(N-phenylethylthiocarbamoyl)cysteine, was the most potent with strong antileukaemic activity: the median growth inhibitory concentrat...

IntroductionSecondary hyperparathyroidism is highly prevalent in kidney transplant recipients, and commonly results in hypercalcaemia; an association to osteopenia and bone fractures has also been observed. Paricalcitol has proved effective to control secondary hyperparathyroidism in chronic kid...

BackgroundArterial stiffness is linked to the progression of atherosclerosis, while activation of vitamin D receptor exerts favorable cardiovascular effects in patients with renal insufficiency. In this study, we investigated the effects of oral treatment with paricalcitol, a potent vitamin D re...

IntroductionSecondary hyperparathyroidism (SHPT) and vitamin D deficiency are common at kidney transplantation and are associated with some early and late complications. This study was designed to evaluate whether paricalcitol was more effective than nutritional vitamin D for controlling SHPT in...

IntroductionChronic kidney disease is a major public health problem. In the last decade, it has been shown that the early stages of chronic kidney disease are associated with an inflammatory condition involving an increased risk of cardiovascular morbidity and long-term mortality. In patients wi...

ResumenAntecedentes y objetivosEl paricalcitol, un activador selectivo del receptor de la vitamina D, se utiliza en el tratamiento del hiperparatiroidismo secundario en el receptor de trasplante renal. Estudios tanto clínicos como experimentales realizados en pacientes renales no trasplantados ...

sBackground and aimsThe nature of the link (causal vs non-causal) between low 1,25-OH vitamin D and insulin resistance (IR) in patients with chronic kidney disease (CKD) remains elusive. We have now made a post hoc analysis of the effect of vitamin D receptor activation by paricalcitol on IR in ...

Depression is highly prevalent in patients suffering from chronic inflammatory diseases. Dysregulated neuroinflammation and concomitant activated microglia play a pivotal role in the pathogenesis of depression. Paricalcitol (Pari), a vitamin D2 analogue, has been demonstrated to exert anti-infla...

Background and objectivesParicalcitol, a selective vitamin D receptor activator, is used to treat secondary hyperparathyroidism in kidney transplant patients. Experimental and clinical studies in non-transplant kidney disease patients have found this molecule to have anti-inflammatory properties...

The halogenated porphyrin, 2,3,7,8,12,13,17,18-octabromo-5,10,15,20-tetrakis(pentafluorophenyl)porphyriato-iron(III) chloride, [Fe(TFPPBr8)Cl], catalyzes the oxidation of cyclohexene in the presence of molecular oxygen or iodosobenzene. With PhIO, 77% epoxide is observed, consistent with a mecha...

Starting from 6-variated 3-methoxy- and 3-chloro-2H-1,4-oxazin-2-ones 4a–e the synthesis of a series of 6-methoxy- and 6-chloro-2(1H)-pyridinone acyclo-C-nucleosides 2a–d and 3a–d was accomplished. Diels-Alder reaction of the oxazinones 4a–e with propargyl bromide yielded the corresponding 3...

Novel two-dimensional π-conjugated molecules, i.e., 5′,5″′-((9,10-bis((4-hexylphenyl)ethynyl)anthracene-2,6-diyl)bis(ethyne-2,1-diyl))bis(5-hexyl-2,2′-bithiophene) (2,6-HBT) and 5′,5″′-((2,6-bis((4-hexylphenyl)ethynyl)anthracene-9,10-diyl)bis(ethyne-2,1-diyl))bis(5-hexyl-2,2′-bithiophen...

New donor-σ-acceptor (D-σ-A) molecules of (HAT)–n(PCBM) (where n = 1 and 2; PCBM refers to [6,6]-phenyl C61-butyric acid methyl ester and HAT refers to 5,5′-(9,10-bis((4-hexylphenyl)ethynyl)anthracene-2,6-diyl)bis(ethyne-2,1-diyl)bis(2-hexylthiophene)) were successfully synthesized for study...

We have successfully synthesized and characterized H-shaped anthracene-based semiconducting molecules that are solution processable. They were synthesized using 9,10-bis((4-hexylphenyl)ethynyl)anthracene via the Stille coupling reaction. The two molecules not only form uniformly smooth films on ...

4,5-Secocholestane (1a) and 4-methyl-4,5-secocholestane (1b) were synthesized from cholesterol (2) in five and seven steps, respectively. The key intermediate, 5-oxo-4,5-secocholestan-4-al (7) was reduced by the Clemmensen method to afford 1a. Meanwhile, 7 underwent selective Wittig reaction, Cl...

5α-(17R,20R)-14,15-Secocholestane (12) was synthesized from cholesterol (1) in 12 steps. The key intermediate, 5α-cholest-14-en-3β-yl acetate (4), underwent ozonization, reduction, hydrolysis, and oxidation to provide 5α-14,15-secocholesta-3,14,15-trione (8). One of the Clemmensen reduction ...